Wall Street Beat
Hologic CEO gives glowing review to major stakeholder and activist investor Carl Icahn | Medtech Wall Street news for the week of August 4, 2014
Thoratec’s new study, $30M buyback can’t stave off Wall Street exodus after dismal Q2
Report: Valeant’s hostile takeover hopes fade as Allergan war continues
Symmetry Medical sells its OEM biz to Tecomet for $450M
Symmetry Medical’s (NYSE:SMA) going through some big changes, selling off its orthopedics components division and spinning out its surgical business.
Cardinal Health struggles but beats The Street in Q4
Ohio healthcare giant Cardinal Health (NYSE:CAH) got no Wall Street love after posting estimate-beating earnings today.
Hologic’s CEO praises its activist investor
Ex-CEO Pignatelli backs down, but not out, in spat with Biolase
Report: Lantheus spikes IPO plans
Lantheus Medical Imaging reportedly spiked an initial public offering it hoped would raise $125 million, citing "poor market conditions," Renaissance Capital reported.